Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
QURE — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

16.56

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.42

EPS Last/This Y

0.02

EPS This/Next Y

0.84

Price

46.38

Target Price

68

Analyst Recom

1.36

Performance Q

92.22

Upside

-405.4%

Beta

0.93

Ticker: QURE



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-14QURE41.510.190.19200498
2026-07-15QURE41.030.190.64201681
2026-07-16QURE39.370.190.24202549
2026-07-17QURE40.270.191.27205746
2026-07-20QURE39.680.180.57123257
2026-07-21QURE40.050.180.64124454
2026-07-22QURE40.410.190.36124961
2026-07-23QURE39.550.190.02128088
2026-07-24QURE390.190.06132677
2026-07-27QURE38.230.180.08137635
2026-07-28QURE36.70.180.26138615
2026-07-29QURE40.030.170.32142685
2026-07-30QURE42.210.181.13144488
2026-07-31QURE43.70.180.67145147
2026-08-03QURE44.040.190.05145648
2026-08-04QURE43.920.190.10145968
2026-08-05QURE44.260.190.05147890
2026-08-06QURE45.450.190.81148592
2026-08-07QURE46.40.200.42150746
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-14QURE41.51-18.8- -3.16
2026-07-15QURE41.01-18.8- -3.16
2026-07-16QURE39.33-18.8- -3.16
2026-07-17QURE40.26-18.8- -3.16
2026-07-20QURE39.70-18.8- -3.16
2026-07-21QURE40.09-18.8- -3.16
2026-07-22QURE40.39-18.8- -3.16
2026-07-23QURE39.47-18.3- -3.14
2026-07-24QURE38.99-18.3- -3.14
2026-07-27QURE38.22-18.3- -3.14
2026-07-28QURE36.71-18.3- -3.14
2026-07-29QURE40.04-18.3- -3.14
2026-07-30QURE42.23-18.3- -3.14
2026-07-31QURE43.64-18.3- -3.14
2026-08-03QURE44.0333.7- -3.37
2026-08-04QURE44.0333.7- -3.37
2026-08-05QURE44.3230.5- -3.48
2026-08-06QURE45.4030.5- -3.48
2026-08-07QURE46.3831.0- -3.44
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-14QURE-7.85-3.7918.73
2026-07-15QURE-7.52-3.7918.73
2026-07-16QURE-7.52-3.7918.73
2026-07-17QURE-7.52-3.7918.73
2026-07-20QURE-7.52-4.1018.73
2026-07-21QURE-7.52-4.1018.73
2026-07-22QURE-7.52-4.1018.73
2026-07-23QURE-7.52-4.1018.73
2026-07-24QURE-7.52-4.1018.73
2026-07-27QURE-7.52-7.4516.89
2026-07-28QURE-7.52-7.4516.89
2026-07-29QURE-7.52-7.4516.89
2026-07-30QURE-7.52-7.4516.89
2026-07-31QURE-7.52-7.4516.89
2026-08-03QURE-7.38-7.4916.56
2026-08-04QURE-7.38-7.4916.56
2026-08-05QURE-7.38-7.4916.56
2026-08-06QURE-7.38-7.4916.56
2026-08-07QURE-7.38-7.4916.56
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-1.22

Avg. EPS Est. Current Quarter

-0.82

Avg. EPS Est. Next Quarter

-0.8

Insider Transactions

-7.38

Institutional Transactions

-7.49

Beta

0.93

Average Sales Estimate Current Quarter

5

Average Sales Estimate Next Quarter

6

Fair Value

Quality Score

45

Growth Score

37

Sentiment Score

94

Actual DrawDown %

35.1

Max Drawdown 5-Year %

-90.1

Target Price

68

P/E

Forward P/E

PEG

P/S

172.47

P/B

9.93

P/Free Cash Flow

EPS

-4.05

Average EPS Est. Cur. Y​

-3.44

EPS Next Y. (Est.)

-2.59

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1350.73

Relative Volume

0.87

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-89.1

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.28

EBIT Estimation

◆ QURE Healthcare
$46.42
📉
Swing / Pullback
Buy the dip on strong trends
57 /100
WATCH
Trend
20/20
Pullback
6/25
Volume
7/15
Valuation
10/20
TP/AR
6/10
Options
8/10
RSI
66.2
Range 1M
84.3%
Sup Dist
4.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
39 /100
WEAK
Momentum
11/25
Growth
11/30
Estimates
5/20
Inst/Vol
4/15
Options
8/10
EPS Yr
-13.2%
EPS NY
23.8%
52W%
59.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +46.5% upside
Quality
3/30
Valuation
10/30
Growth
10/25
Stability
4/10
LT Trend
4/5
Upside
+46.5%
Quality
45
Click a card to see score breakdown Full Analysis →
QURE — P/E HistoricalBiotechnology
uniQure N.V.
Sector: Healthcare
Industry: Biotechnology
Employees: 221
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
QURE

Latest News

—
Caricamento notizie per QURE…
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading